BioSpace News Archive

Business

aTyr Pharma Announces Appointment of Robert W. Ashworth, PhD, as Vice President of Regulatory Affairs

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the appointment of Robert W. Ashworth, Ph.D., to Vice President, Regulatory Affairs.

October 6, 2021
·
6 min read
Sunshine Biopharma Files a Patent Application Covering mRNA Molecules for Treatment of Neurodegenerative Diseases

Sunshine Biopharma Inc. today announced that it has filed a patent application for a potential new treatment for neurodegenerative disorders.

October 6, 2021
·
5 min read
Biotech Beach

Aadi Bioscience to Present New Preclinical Data on nab-Sirolimus (ABI-009) at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

- Poster Presentation to go Live on October 7, 2021 at 9 a.m. ET and on Demand at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

October 6, 2021
·
5 min read
Business

CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

Centogene N.V. and Twist Bioscience Corporation announced today that they have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases.

October 6, 2021
·
7 min read
Pharm Country

NEXGEL Announces Positive Results From its Antimicrobial Study of its SilverSeal® Product Line

NEXGEL, Inc. (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced positive results from its validation study, demonstrating the antimicrobial properties of its SilverSeal® product line.

October 6, 2021
·
3 min read
Drug Development

Viracta Therapeutics Initiates Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors

Viracta Therapeutics, Inc. today announced the initiation of a multinational Phase 1b /2 trial in patients with EBV + solid tumors.

October 6, 2021
·
5 min read
Drug Development

Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial

 Vaxart, Inc. (NASDAQ: VXRT) today announced that it has begun recruiting subjects for its Phase II COVID-19 oral tablet vaccine clinic

October 6, 2021
·
5 min read
Drug Development

Lumen Bioscience Awarded Federal Funding to Advance Covid-19 Antibody Cocktail through Phase 2 Clinical Evaluation

Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced new development funding from the US Army for its Covid-19 monoclonal antibody drug cocktail.

October 6, 2021
·
6 min read
BioForest

OncoResponse Announces Presentations at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC 2021)

OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders, today announced that it will present three abstracts at the upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting being held in Washington D.C.

October 6, 2021
·
3 min read
Job Trends

IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded Capabilities

IQVIA Announces Opening of New Q 2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded Capabilities

October 6, 2021
·
4 min read